Ploch, Philippe; Marquardt, Jens U.; Fritzsche, Susanne et al.
Second Line Therapy in Autoimmune Hepatitis: is Mycophenolate Mofetil an effective option?HEPATOLOGY. Bd. 56. 2012 S. 724A-724A
de Groot, K.; Maerker-Hermann, E.
Secondary vasculitides and vasculitis mimicsZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 71. H. 9. 2012 S. 771-774
Yoshida, Shuhei; Liu, Susan B.; Chung, Jeanhee et al.
Selective inhibition of platelet derived growth factor (PDGF-BB) using a therapeutic monoclonal antibody potently suppresses experimental biliary fibrosisHEPATOLOGY. Bd. 56. 2012 S. 778A-778A
Mueller, A; Bachmann, E; Linnig, M et al.
Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell linesCANCER CHEMOTHERAPY AND PHARMACOLOGY. Bd. 69. H. 6. 2012 S. 1601-1615
Teufel, A; Marquardt, JU; Staib, F et al.
Snapshot liver transcriptome in hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 56. H. 4. 2012 S. 990-992
Weinmann, Arndt; Niederle, Ina Maria; Koch, Sandra et al.
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantationDIGESTIVE AND LIVER DISEASE. Bd. 44. H. 5. 2012 S. 432-437
Sprinzl, Martin F.; Reisinger, Florian; Hartmann, Daniel et al.
Sorafenib modulates tumor associated macrophages and enhances anti-cancer NK cell responsesHEPATOLOGY. Bd. 56. 2012 S. 629A-629A
Zeuzem, Stefan; Soriano, Vincent; Asselah, Tarik et al.
SOUND-C2: SVR4, 12, and 24 concordance in genotype (GT) 1 HCV patients receiving interferon (IFN)-free treatment with the HCV NS3/4A protease inhibitor BI 201335 and the NS5B polymerase inhibitor BI 207127HEPATOLOGY. Bd. 56. 2012 S. 569A-569A
Krause, A.; Maerker-Hermann, E.
Spondyloarthritis including psoriatic arthritisDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 137. H. 40. 2012 S. 2031-2033
Yoshida, Shuhei; Kornek, Miroslaw; Popov, Yury et al.
Sublethal heat exposure induces EMT-like changes, enhanced proliferation and accelerated growth of HCC in vitro and in vivoHEPATOLOGY. Bd. 56. 2012 S. 623A-623A